FDA Approves Tlando (testosterone undecanoate) for Male Hypogonadism

EWING, N.J., March 29, 2022 (GLOBE NEWSWIRE) — Antares Pharma, Inc., (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration granted final approval for…Original Article